Wednesday, July 22, 2026 | 11:55 PM ISTहिंदी में पढें
Jagsonpal Pharmaceuticals Ltd
Board Meeting Intimation for Consideration Of Financial Results For The Quarter And Year Ended March 31 2025 And Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025.
04:52 PM, 29th Apr 2025
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 inter alia to consider and approve Financial results for the quarter and year ended March 31 2025 and recommendation of Dividend if any for the financial year ended March 31 2025